Siga Technologies INC Recognition of Deferred Revenue
Siga Technologies INC (SIGA) reported Recognition of Deferred Revenue of $0 for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-05.
Discontinued › Income Statement › Other Income
us-gaap:RecognitionOfDeferredRevenue · last filed 2019-11-05
- 2019-09-30: Recognition of Deferred Revenue 9 month $0.00.
- 2018-09-30: Recognition of Deferred Revenue 9 month $281.95M.
| Period end | Recognition of Deferred Revenue 9 month |
|---|---|
| 2019-09-30 | $0.00 10-Q · filed 2019-11-05 |
| 2018-09-30 | $281.95M 10-Q · filed 2019-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |